Viropharma (VPHM) is off $2.17 to $30.52 and options volume on the biotech is running 6X the daily average, being driven by 3400-lot of Apr 25 puts traded for 50 cents when the market was 35 to 55 cents. 4,208 traded and levels of implied volatility in VPHM moved up 15.5 percent to 50.5. Bearish trading is possibly in anticipation of a short-term pullback in the stock. VPHM has surged over 80 percent since September and closed at a new decade high of $32.69 Monday.The company released positive trial results for a jointly developed drug called Cinryze and will present at a Cowen Healthcare conference tomorrow.
About the Author (Author Profile)
Frederic Ruffy is a well-known trader, writer, and strategist who has spent years educating investors and creating intelligent, insightful, unbiased market observations that are frequently cited by the Wall Street Journal and other financial publications. As senior analyst, Fred provides frequent and regular notes and daily updates for activity of interest.